Jin Chai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Top Venues

Nature communications

Cell death discovery

Hepatology (Baltimore, Md.)

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Guo, Hongjia Zhang, Nan Zhao, Ying Peng, Dongya Shen, Yubin Chen, Xiaoxun Zhang, Can-E Tang, Jin Chai
STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis. Journal of clinical and translational hepatology 12 (8) (2024)
Yan Guo, Hongjia Zhang, Nan Zhao, Ying Peng, Dongya Shen, Yubin Chen, Xiaoxun Zhang, Can-E Tang, Jin Chai
STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis. Journal of clinical and translational hepatology 12 (8) (2024)
Liangjun Zhang, Pingfan Xie, Mingqiao Li, Xiaoxun Zhang, Shuke Fei, Nan Zhao, Ling Li, Ziqian Xu, Wan Tang, Guanyu Zhu, Zhixian Zhu, Zuzhi Xu, Jian-Wei Li, Chengcheng Zhang, James L Boyer, Wensheng Chen, Shi-Ying Cai, Qiong Pan, Jin Chai
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation. Hepatology (Baltimore, Md.) (2024)
Liangjun Zhang, Qiong Pan, Lu Zhang, Haihan Xia, Junwei Liao, Xiaoxun Zhang, Nan Zhao, Min Liao, Ya Tan, Qiao Li, Jinfei Zhu, Ling Li, Shijun Fan, Jian-Wei Li, Chengcheng Zhang, Shi-Ying Cai, James L Boyer, Jin Chai
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling. Hepatology (Baltimore, Md.) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Min Liao, Junwei Liao, Jiaquan Qu, Pan Shi, Ying Cheng, Qiong Pan, Nan Zhao, Xiaoxun Zhang, Liangjun Zhang, Ya Tan, Qiao Li, Jin-Fei Zhu, Jianwei Li, Chengcheng Zhang, Shi-Ying Cai, Jin Chai
Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NFκB/Caspase-1/GSDMD signaling in cholestasis. Cell death discovery 9 (1) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Liangjun Zhang, Qiong Pan, Lu Zhang, Haihan Xia, Junwei Liao, Xiaoxun Zhang, Nan Zhao, Min Liao, Ya Tan, Qiao Li, Jinfei Zhu, Ling Li, Shijun Fan, Jian-Wei Li, Chengcheng Zhang, Shi-Ying Cai, James L Boyer, Jin Chai
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling. Hepatology (Baltimore, Md.) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Xiuru Mao, Xiaoxun Zhang, Ziqian Xu, Nan Zhao, Lei Fu, Shifang Peng, Jin Chai
Hepatic interleukin 32 attenuates liver injury through repression of necroptosis in cholestasis. Journal of digestive diseases (2023)
Min Liao, Junwei Liao, Jiaquan Qu, Pan Shi, Ying Cheng, Qiong Pan, Nan Zhao, Xiaoxun Zhang, Liangjun Zhang, Ya Tan, Qiao Li, Jin-Fei Zhu, Jianwei Li, Chengcheng Zhang, Shi-Ying Cai, Jin Chai
Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NFκB/Caspase-1/GSDMD signaling in cholestasis. Cell death discovery 9 (1) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Min Liao, Junwei Liao, Jiaquan Qu, Pan Shi, Ying Cheng, Qiong Pan, Nan Zhao, Xiaoxun Zhang, Liangjun Zhang, Ya Tan, Qiao Li, Jin-Fei Zhu, Jianwei Li, Chengcheng Zhang, Shi-Ying Cai, Jin Chai
Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NFκB/Caspase-1/GSDMD signaling in cholestasis. Cell death discovery 9 (1) (2023)
Ming-Yue Wu, Yun-Jun Ge, Er-Jin Wang, Qi-Wen Liao, Zheng-Yu Ren, Yang Yu, Guoyuan Zhu, Chun-Ping Liu, Meng-Ni Zhang, Huanxing Su, Han-Ming Shen, Ye Chen, Lei Wang, Yi-Tao Wang, Min Li, Zhaoxiang Bian, Jin Chai, Richard D Ye, Jia-Hong Lu
Enhancement of efferocytosis through biased FPR2 signaling attenuates intestinal inflammation. EMBO molecular medicine (2023)
Xiaoxun Zhang, Ling Li, Nan Zhao, Qiong Pan, Liangjun Zhang, Qiaoling Xie, Xuan Li, Min Liao, Qiao Li, Xinglin Huang, Sheng Chen, Jianwei Li, Huaizhi Wang, Xuequan Huang, Shijun Fan, Yunxia Wang, Man Li, Jin Chai
A novel role for interleukin 32 in cholestasis. Clinical and translational medicine 11 (11) (2022)
Ying Peng, Qinglin Wei, Yun Liu, Zhenyu Wu, Hongjia Zhang, Hongbo Wu, Jin Chai
Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy. Gastroenterology research and practice 2021 (2021)
Qiong Pan, Gang Luo, Jiaquan Qu, Sheng Chen, Xiaoxun Zhang, Nan Zhao, Jingjing Ding, Hong Yang, Mingqiao Li, Ling Li, Ying Cheng, Xuan Li, Qiaoling Xie, Qiao Li, Xueqian Zhou, Huiling Zou, Shijun Fan, Lingyun Zou, Wei Liu, Guohong Deng, Shi-Ying Cai, James L Boyer, Jin Chai
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis. EMBO molecular medicine 13 (11) (2021)